Our Company / Alfasigma at glance

Pharmaceuticals
with passion

Alfasigma is an international pharmaceutical company founded in Italy, operating in more than 100 countries worldwide (through direct branches, affiliates and subsidiaries), with approximately 4,000 employees and a turnover of approximately EUR 1.4 billion in 2023.

 
With more than 75 years of history, Alfasigma has a long track record in the research, development, production and distribution of innovative therapeutic indications. Its product portfolio spans specialty care, primary care and consumer care in five main areas: Gastroenterology, in which it is a leader, Vascular, Rheumatology, Metabolic, Nutraceuticals & Medical foods.


The historical headquarters are in Bologna, Italy,  with an additional office in Milan, while there are 6 production sites: in Italy, in Pomezia (RM), Alanno (PE), Sermoneta (LT) and Trezzano Rosa (MI) and abroad in Tortosa, Spain and in Shreveport (Louisiana), United States. The Research & Development Centres are located in Italy: in Pomezia (RM) and in the Kilometro Rosso Science and Technology Park in Bergamo.

Geographic coverage

Subsidiaries

24 countries​

Direct subsidiaries

Turnover

€ 1,367

millions in 2023

0%

5 proprietary molecules
Rifaximin, Sulodexide, Carnitine, L-Methylfolate, Parnaparin

Contract Manufacturing – Business Unit

Alongside its traditional business, the company is also playing a leading role supplying to other multinational and Italian pharmaceutical companies thanks to its Contract Manufacturing division, which has been on a constant growth trajectory since 2017 with a CAGR (Compound Annual Growth Rate) of 10.2%.

2

R&D Lab centers

6

Manufacturing plants

24

Countries with direct subsidiaries worldwide

Read More

Alfasigma was established in 2015 from the merging of two big companies – Alfa Wassermann and Sigma-Tau – both with over 60 years of history behind them.
In 2019 Alfasigma adopted a new Leadership Model that prescribes five preferred behaviors to be put into practice daily.
Social contract between the company and internal and external stakeholders having a normative value for the entire Alfasigma system.
×

You’re entering Alfasigma global website

I agree